Get the Stockscreener App
0.00
100.00%
-0.0322
Gritstone Bio Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Gritstone Bio Inc is a biotechnology company. The company is engaged in developing personalized cancer immunotherapies to fight multiple cancer types and infectious diseases. It is building a pipeline of Immunotherapies product candidates for patients with solid tumors, which includes GRANITE, SLATE, and CORAL, among others.
See More
Previous Close:
$0.0322
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$3.80M
Revenue:
$1.33M
Net Income/Loss:
$-138.49M
P/E Ratio:
0.00
EPS:
-1.26
Net Cash Flow:
$-126.22M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$3.17
Gritstone Bio Inc Stock (GRTS) Company Profile
Name
Gritstone Bio Inc
Sector
Industry
Phone
(510) 871-6100
Address
5959 HORTON STREET, SUITE 300, EMERYVILLE, CA
Gritstone Bio Inc Stock (GRTS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-31-23 | Initiated | Evercore ISI | Outperform |
| Mar-28-23 | Initiated | B. Riley Securities | Buy |
| Oct-31-22 | Initiated | Piper Sandler | Overweight |
| Aug-22-22 | Downgrade | Goldman | Neutral → Sell |
| Dec-15-21 | Resumed | Goldman | Neutral |
| Oct-15-21 | Resumed | BTIG Research | Buy |
| Jan-20-21 | Downgrade | Robert W. Baird | Outperform → Underperform |
| Jul-26-19 | Initiated | Robert W. Baird | Outperform |
| Mar-15-19 | Initiated | Raymond James | Outperform |
| Mar-07-19 | Initiated | H.C. Wainwright | Buy |
| Oct-23-18 | Initiated | BTIG Research | Buy |
| Oct-23-18 | Initiated | Goldman | Neutral |
View All
Gritstone Bio Inc Stock (GRTS) Latest News
Meet The Attys Behind Biotech Co. Gritstone's Ch. 11 - Law360
Volatility Of Gritstone Bio Inc (GRTS) Reaches 28.56%: Make Sure To Keep Your Seat Tight! - Stocks Register
GRTS stock plunges to 52-week low of $0.05 amid market challenges - Investing.com
GRTS stock plunges to 52-week low of $0.05 amid market challenges By Investing.com - Investing.com South Africa
Gritstone bio announces layoffs and Nasdaq delisting By Investing.com - Investing.com Australia
Gritstone bio announces layoffs and Nasdaq delisting - Investing.com
GRTS’s Stock Market Puzzle: Piecing Together 2023’s Performance - The InvestChronicle
Gritstone bio, Inc.(NasdaqGS: GRTS) dropped from S&P TMI Index - Marketscreener.com
GRTS’s price-to-cash ratio: Is it a good investment at the moment? - US Post News
Gritstone’s bankruptcy filing reveals biotech’s tough choices - The Business Journals
Recent Insider Activity Suggests Potential Gains for Gritstone Bio Inc (GRTS) - Knox Daily
Holdings of Gritstone Bio Inc (GRTS) are aligned with the stars - SETE News
In the Green: Gritstone Bio Inc (GRTS) Closes at 0.05, Up/Down -18.04 from Previous Day - The Dwinnex
Gritstone Bio Inc (GRTS) Stock: A Year of Stock Market Ups and Downs - The InvestChronicle
Gritstone Bio Inc (NASDAQ:GRTS) stock: Is this a flash in the pan today? - US Post News
Gritstone Oncology Pursues Restructuring Through Chapter 11 - Yahoo Finance
Gritstone stock plunges to 52-week low of $0.08 amid market challenges - Investing.com India
Biotech Co. Gritstone Hits Ch. 11 With Over $100M Debt - Law360
Covid-Shot Maker Goes Bankrupt After Trailing Pfizer, Moderna - MSN
Gritstone goes under after gruesome year - The Pharma Letter
GRTS Stock Sees Decline of Approximately -3.69% in Last Five Days - Knox Daily
Why Gritstone Bio (GRTS) Stock Is Down 64% Today - Benzinga
East Bay biotech company files for Chapter 11 bankruptcy protectionSan Francisco Business Times - The Business Journals
Gritstone stock plunges to 52-week low of $0.08 amid market challenges By Investing.com - Investing.com South Africa
Gritstone bio files for Chapter 11 bankruptcy protection, shares tumble (NASDAQ:GRTS) - Seeking Alpha
Gritstone bio Takes Action to Preserve Value and Strengthen Capital Structure - The Bakersfield Californian
Gritstone bio, Inc. Filed for Bankruptcy - Marketscreener.com
JMP Securities lifts Gritstone Bio Inc [GRTS] price estimate. Who else is bullish? - The DBT News
Gritstone Bio Inc (GRTS) can make a big difference with a little luck - SETE News
Gritstone Bio Inc [GRTS] PRESIDENT AND CEO makes an insider sale of 24,263 shares worth $18156.0. - Knox Daily
Gritstone Bio Inc (GRTS) Stock: Navigating a Year of Volatility - The InvestChronicle
Are Gritstone Bio Inc’shares a good deal? - US Post News
Closing Figures: Gritstone Bio Inc (GRTS)’s Negative Finish at 0.19, Down -5.00 - The Dwinnex
B. Riley Weighs in on Gritstone bio, Inc.’s Q3 2024 Earnings (NASDAQ:GRTS) - Defense World
Jones Trading Downgrades Gritstone bio (GRTS) - MSN
Granite Weighs Gritstone Down - Scrip
Gritstone downgraded by Jones, B. Riley over cancer vaccine data (NASDAQ:GRTS) - Seeking Alpha
It is Poised to be a Bull Market for Gritstone Bio Inc (GRTS) - SETE News
Gritstone bio (NASDAQ:GRTS) Receives Neutral Rating from B. Riley - MarketBeat
Gritstone bio stock downgraded amid trial data and cash concerns By Investing.com - Investing.com UK
Gritstone Oncology stock hits 52-week low at $0.4 amid market challenges - Investing.com Australia
Gritstone bio shares cut to hold on interim data concerns By Investing.com - Investing.com Canada
Gritstone bio’s (GRTS) Neutral Rating Reiterated at HC Wainwright - Defense World
Penny Stock Gritstone Bio Hires Advisor To Evaluate Options, Analyst Downgrades Stock As Data 'Insufficient To Excite Many Investors' - AOL
Key Takeaways From Gritstone Bio Analyst Ratings - Benzinga
The Significance of Moving Averages in Gritstone Bio Inc Inc. (GRTS) Price Performance - The InvestChronicle
Gritstone bio reports positive interim Phase 2 data - Investing.com
Gritstone stock craters 50% in wake of Phase 2 data, corporate update (NASDAQ:GRTS) - Seeking Alpha
For Gritstone Bio Inc [GRTS], Analyst sees a rise to $4. What next? - The DBT News
Gritstone bio (NASDAQ:GRTS) Downgraded by JMP Securities to Market Perform - MarketBeat
Gritstone bio's SWOT analysis: cancer vaccine maker's stock faces pivotal moment - Investing.com India
Gritstone Bio Inc Stock (GRTS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.75%
0.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):